From Activated Partial Thromboplastin Time to Antifactor Xa and Back AgainThe Evolution of Monitoring Unfractionated Heparin.

Jori E MayRance Chad SiniardLaura J TaylorMarisa B MarquesRadhika Gangaraju

Published in: American journal of clinical pathology (2021)

Our experience demonstrates key challenges in anticoagulation and highlights the importance of clinical pathologists in helping health systems adapt to the changing anticoagulation landscape.

Keyphrases

venous thromboembolism
atrial fibrillation
single cell
growth factor